SEC 13F Intelligence

Ghost Tree Capital, LLC / CRNX

Ghost Tree Capital, LLC’s Crinetics Pharmaceuticals In Position

Does Ghost Tree Capital, LLC own Crinetics Pharmaceuticals In (CRNX)? Yes — 150.0K shares worth $8M (+2.32% of its 13F portfolio) as of Q3 2024, down from 240.0K shares the prior filed quarter.

Position Value
$8M
Q3 2024
Shares
150.0K
% of Portfolio
+2.32%
Quarters Held
9
currently held

Position History CRNX

Reported value by quarter
Q2 ’21: $5MQ2 ’21Q3 ’21: $3MQ4 ’21: $3MQ4 ’21Q1 ’22: $2MQ3 ’23: $3MQ3 ’23Q4 ’23: $2MQ1 ’24: $9MQ1 ’24Q2 ’24: $11MQ3 ’24: $8MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024150.0K$8M+2.32%
Q2 2024240.0K$11M+3.37%
Q1 2024200.0K$9M+2.59%
Q4 202365.0K$2M+0.76%
Q3 2023101.4K$3M+0.99%
Q1 202285.0K$2M+0.40%
Q4 2021118.3K$3M+1.20%
Q3 2021150.0K$3M+0.92%
Q2 2021243.3K$5M+1.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of CRNX.